VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Holdings in LifeStance Health Group, Inc. $LFST

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 139,500 shares of the company’s stock, valued at approximately $721,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. TD Asset Management Inc bought a new stake in LifeStance Health Group during the second quarter valued at about $780,000. Blair William & Co. IL acquired a new stake in LifeStance Health Group in the second quarter worth about $70,000. Public Employees Retirement System of Ohio acquired a new stake in LifeStance Health Group in the second quarter worth about $70,000. Park Edge Advisors LLC acquired a new stake in LifeStance Health Group in the second quarter worth about $52,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in LifeStance Health Group by 1.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company’s stock worth $4,100,000 after acquiring an additional 11,331 shares in the last quarter. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Trading Up 1.2%

Shares of NASDAQ:LFST opened at $5.20 on Friday. LifeStance Health Group, Inc. has a 52-week low of $3.74 and a 52-week high of $8.61. The stock has a market cap of $2.02 billion, a price-to-earnings ratio of -104.00 and a beta of 1.17. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.19. The business has a 50-day moving average price of $5.35 and a 200-day moving average price of $5.39.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The firm had revenue of $345.31 million during the quarter, compared to analysts’ expectations of $345.05 million. During the same period last year, the business posted ($0.06) earnings per share. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts predict that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. UBS Group raised their price target on LifeStance Health Group from $8.50 to $9.00 and gave the stock a “buy” rating in a report on Friday, August 8th. BTIG Research assumed coverage on LifeStance Health Group in a report on Friday, July 25th. They issued a “buy” rating and a $8.00 price target for the company. Weiss Ratings reissued a “sell (e+)” rating on shares of LifeStance Health Group in a report on Wednesday, October 8th. Wall Street Zen downgraded LifeStance Health Group from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Zacks Research raised LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $8.50.

Insider Transactions at LifeStance Health Group

In related news, major shareholder Summit Partners L. P sold 8,407,643 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the insider directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Darren M. Black sold 8,407,643 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the transaction, the director owned 33,524,715 shares of the company’s stock, valued at approximately $169,970,305.05. This represents a 20.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 20,407,643 shares of company stock worth $103,466,750 over the last three months. 3.20% of the stock is currently owned by insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.